<DOC>
	<DOC>NCT02191917</DOC>
	<brief_summary>Study 701-201 is a study in patients with late-onset Pompe disease (LOPD). The study will test respiratory muscle strength initially and again after 24 weeks in subjects treated or not treated with BMN 701 .</brief_summary>
	<brief_title>A Study of Repiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<criteria>Willing and able to provide written informed consent, after the nature of the study has been explained, and prior to any studyrelated procedures Documented diagnosis with lateonset Pompe disease At least 18 years of age at study entry Willing and able to comply with all study procedures Requires ventilatory support while awake and in the upright position Concurrent disease, medical condition, or extenuating circumstance that, in the opinion of the investigator, might compromise patient wellbeing, study completion, or data collection Allergy to tools or procedures used for respiratory muscle testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>